Combotope Therapeutics ApS — Credit Rating and Financial Key Figures
CVR number: 44308266
Diplomvej 381, 2800 Kongens Lyngby
olablixt@combotope.com
Income statement (kDKK)
2024 | |
---|---|
Fiscal period length | 12 |
Net sales | |
Gross profit | -2 059.79 |
Employee benefit expenses | - 733.67 |
Total depreciation | -9.17 |
EBIT | -2 802.63 |
Other financial income | 2.69 |
Other financial expenses | -1.55 |
Pre-tax profit | -2 801.49 |
Income taxes | 616.18 |
Net earnings | -2 185.31 |
Assets (kDKK)
2024 | |
---|---|
Intangible assets total | |
Machinery and equipment | 69.43 |
Tangible assets total | 69.43 |
Investments total | 130.44 |
Deferred tax assets | 616.18 |
Long term receivables total | 616.18 |
Inventories total | |
Prepayments and accrued income | 26.14 |
Current other receivables | 50.50 |
Short term receivables total | 76.64 |
Cash and bank deposits | 487.97 |
Cash and cash equivalents | 487.97 |
Balance sheet total (assets) | 1 380.67 |
Equity and liabilities (kDKK)
2024 | |
---|---|
Share capital | 55.30 |
Share premium account | 3 484.70 |
Profit of the financial year | -2 185.31 |
Shareholders equity total | 1 354.69 |
Non-current liabilities total | |
Other non-interest bearing current liabilities | 25.98 |
Current liabilities total | 25.98 |
Balance sheet total (liabilities) | 1 380.67 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.